Form D · Other Health Care
InSite Health, Inc.
Marlton, NJ · CIK 0002012080
Offering snapshot reported Feb 21, 2024 · SEC filing
- Reported sold
- $2.95M Offering amount: $2.95M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2024 | Initial | $2,947,955 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-505685
Simple Agreements for Future Equity
Source: Form D, filed Feb 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Gaeta | Director, Executive |
| Mark Gaeta | Director |
| Stephen Klasko | Director |
| Andrew Zalasin | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
Five Greentree Center, 525 Route 73 Suite 302
Marlton, NJ, 08053
Marlton, NJ, 08053